Growth in this market is primarily driven by the increasing global prevalence of infectious diseases, shift in focus from centralized laboratories to decentralized point-of-care testing, and growth in funding for research on infectious disease diagnostics.
What the Market Looks Like?
[170 Pages Report]The global infectious disease diagnostics market infectious disease diagnostics market was valued at USD 13.93 Billion in 2016 and projected to reach USD 19.35 Billion in 2022, at a CAGR of 5.6%. The base year considered for the study is 2016, and the forecast for the market size is provided for the period between 2017 and 2022.
Increased accessibility and the increasing number of IDD tests conducted are the key drivers for this segment. Globally, the volume of IDD tests is increasing mainly due to the rising geriatric population; increasing prevalence of infectious diseases; increased variety of reagents available and analytical techniques employed; and the continuous launch of newer, faster, and more reliable products.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=116764589
What Drives the Market?
The growth of the Infectious Disease Diagnostics Market is primarily influenced by the following factors:
- Increasing global prevalence of infectious diseases
- Shift in focus from centralized laboratories to decentralized point-of-care testing
- Growth in funding for research on infectious disease diagnostics
Hepatitis diagnostics market formed the largest share. Around 70% to 90% of the people in these regions (below 40 years of age) are reportedly suffering from the disease and around 8% to 20% are carriers of this virus. Another factor contributing to the growth of this market is the increasing adoption of advanced technologies for the diagnosis of hepatitis B.
Read more about Infectious Disease Diagnostics Market@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=116764589
MnM Healthcare 